Indium In-111 Pentetreotide Kit is used for detecting neuroendocrine tumors. It was first introduced by Curium Us Llc in its drug Octreoscan on Jun 2, 1994. 2 different companies have introduced drugs containing Indium In-111 Pentetreotide Kit.

Indium In-111 Pentetreotide Kit Patents

Given below is the list of patents protecting Indium In-111 Pentetreotide Kit, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Octreoscan	US6123916	Therapeutic use of somatostatin peptides	Sep 26, 2017 (Expired)	Curium
Octreoscan	US5776894	Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors	Jul 07, 2015 (Expired)	Curium
Octreoscan	US5753627	Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis	May 19, 2015 (Expired)	Curium

Add above patents to watchlist

Indium In-111 Pentetreotide Kit's Family Patents

Full family tree

Indium In-111 Pentetreotide Kit Generic API Manufacturers

Only one generic application has been filed for Indium In-111 Pentetreotide Kit.

Given below is the list of companies who have filed for Indium In-111 Pentetreotide Kit generic, along with the locations of their manufacturing plants worldwide.